The Xolair dose and dosing interval were determined by total serum immunoglobulin E (IgE) level and body weight at baseline. After 16 to 20 weeks of treatment with Xolair or placebo, each participant ...

CHICAGO (WLS) -- After the FDA approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods, sufferers say they're ...

If you have food allergies, you know the dread: You'll be at a gathering and no one can tell you for sure if there are peanuts or eggs in any of the food. So you take a risk or you don't eat. Now, a ...

Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...

A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. Data ...

Findings showed that compared with placebo, Xolair significantly increased the amount of peanut, milk, egg, and cashew participants could consume without an allergic reaction. The Food and Drug ...

Zavodnick told Pharmaceutical Technology that Excellergy plans to initiate an ex-US Phase I study of its lead ECRI candidate, ...

Xolair is a prescription biologic medicine that is given as an injection under the skin (subcutaneous). It is the only FDA-approved antibody designed to target and block IgE — an underlying driver of ...

Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate ...